Surface Oncology Price Prediction
| SURFDelisted Stock | USD 0.96 0.03 3.23% |
Oversold Vs Overbought
71
Oversold | Overbought |
Using Surface Oncology hype-based prediction, you can estimate the value of Surface Oncology from the perspective of Surface Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Surface Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Surface because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Surface Oncology after-hype prediction price | USD 0.96 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Surface |
Surface Oncology After-Hype Price Prediction Density Analysis
As far as predicting the price of Surface Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Surface Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Surface Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Surface Oncology Estimiated After-Hype Price Volatility
In the context of predicting Surface Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Surface Oncology's historical news coverage. Surface Oncology's after-hype downside and upside margins for the prediction period are 0.96 and 0.96, respectively. We have considered Surface Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Surface Oncology is very steady at this time. Analysis and calculation of next after-hype price of Surface Oncology is based on 3 months time horizon.
Surface Oncology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Surface Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Surface Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Surface Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 3 Events / Month | 4 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.96 | 0.96 | 0.00 |
|
Surface Oncology Hype Timeline
Surface Oncology is at this time traded for 0.96. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Surface is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Surface Oncology is about 0.0%, with the expected price after the next announcement by competition of 0.96. About 46.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.47. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surface Oncology recorded a loss per share of 1.66. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next projected press release will be in about 3 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.Surface Oncology Related Hype Analysis
Having access to credible news sources related to Surface Oncology's direct competition is more important than ever and may enhance your ability to predict Surface Oncology's future price movements. Getting to know how Surface Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Surface Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SYRS | Syros Pharmaceuticals | (0.65) | 9 per month | 0.00 | (0.04) | 19.91 | (15.48) | 111.02 | |
| RPTX | Repare Therapeutics | 0.25 | 9 per month | 3.51 | (0.03) | 7.96 | (6.43) | 25.67 | |
| PSNL | Personalis | 0.58 | 9 per month | 0.00 | (0.12) | 8.46 | (9.47) | 35.38 | |
| EVGN | Evogene | 0.06 | 4 per month | 0.00 | (0.22) | 9.30 | (6.91) | 36.00 | |
| IOVA | Iovance Biotherapeutics | 0.34 | 7 per month | 0.00 | (0.12) | 7.18 | (6.95) | 23.06 |
Surface Oncology Additional Predictive Modules
Most predictive techniques to examine Surface price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Surface using various technical indicators. When you analyze Surface charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Surface Oncology Predictive Indicators
The successful prediction of Surface Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Surface Oncology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Surface Oncology based on analysis of Surface Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Surface Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Surface Oncology's related companies.
Story Coverage note for Surface Oncology
The number of cover stories for Surface Oncology depends on current market conditions and Surface Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Surface Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Surface Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Surface Oncology Short Properties
Surface Oncology's future price predictability will typically decrease when Surface Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Surface Oncology often depends not only on the future outlook of the potential Surface Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Surface Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 55.8 M | |
| Cash And Short Term Investments | 124.8 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Surface Stock
If you are still planning to invest in Surface Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surface Oncology's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |